ClinicalTrials.Veeva

Menu

Tricuspid Regurgitation in the ElderlY (TREY)

A

Al-Azhar University

Status

Active, not recruiting

Conditions

Tricuspid Regurgitation

Treatments

Diagnostic Test: Echocardiography

Study type

Observational

Funder types

Other

Identifiers

NCT05784883
ACRI-01

Details and patient eligibility

About

Tricuspid regurgitation (TR) is the second most common VHD after MR. Its prevalence also increases with age, with an estimated incidence of up to 6% in elderly population. When adjusted to age (among other confounders), survival is worse for patients with moderate and severe TR. We aim to explore the prevalence, mechanisms, and clinical implications of tricuspid valve regurgitation in elderly subjects screened at a tertiary center in Cairo, Egypt.

Enrollment

700 patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All comer patients ≥60-year-old presenting to the echocardiography clinic

Exclusion criteria

  • Poor acoustic window.

Trial design

700 participants in 1 patient group

Consecutive patients ≥60-year-old presenting to the echocardiography clinic
Treatment:
Diagnostic Test: Echocardiography

Trial contacts and locations

1

Loading...

Central trial contact

Mohammad Abdelghani, MD, PhD; Mahmoud Abdelshafy, MBBCh, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems